Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by hydrocarbsson Sep 08, 2019 9:57pm
105 Views
Post# 30107240

RE:RE:Theralase Technologies investment dead money

RE:RE:Theralase Technologies investment dead moneySo who would not be buying now?

51 trades Thurs and 49 on Fri.  Booming

With shares traded in the 260,000 range that's 5,000 a trade average.

With the shorters having oh I don't know, 30,000,000 shares to use in covering shorts and only 260,000 a day in normal days.... 
could be months before the pressure abates...



Only those with no foresight.. 

Like those who wonder, just who is in charge?

Two CEOs, one for the Drug division, one for the Devise division...

Who is Chairman of the Board...you know, the Board of Directors...

The one that is so messed up, the Ontario security authorities had to cite them....

PS and I hold some shares...






Bullboard Posts